BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1312 related articles for article (PubMed ID: 25857211)

  • 21. Resolution phase lipid mediators of inflammation: agonists of resolution.
    Serhan CN; Chiang N
    Curr Opin Pharmacol; 2013 Aug; 13(4):632-40. PubMed ID: 23747022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enriched Marine Oil Supplements Increase Peripheral Blood Specialized Pro-Resolving Mediators Concentrations and Reprogram Host Immune Responses: A Randomized Double-Blind Placebo-Controlled Study.
    Souza PR; Marques RM; Gomez EA; Colas RA; De Matteis R; Zak A; Patel M; Collier DJ; Dalli J
    Circ Res; 2020 Jan; 126(1):75-90. PubMed ID: 31829100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Resolution of inflammation--pharmacological aspects].
    Leon MM; Jaba IM; Cozma CD; Albu E; Bahnea R; Mungiu OC
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):470-6. PubMed ID: 21870743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural resolution of inflammation.
    Freire MO; Van Dyke TE
    Periodontol 2000; 2013 Oct; 63(1):149-64. PubMed ID: 23931059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration.
    Serhan CN; Chiang N; Dalli J
    Mol Aspects Med; 2018 Dec; 64():1-17. PubMed ID: 28802833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resolution of inflammation in oral diseases.
    Eltay EG; Van Dyke T
    Pharmacol Ther; 2023 Jul; 247():108453. PubMed ID: 37244405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators.
    Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2008; 79(3-5):157-63. PubMed ID: 19008087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pro-resolving lipid mediators: Agents of anti-ageing?
    Doyle R; Sadlier DM; Godson C
    Semin Immunol; 2018 Dec; 40():36-48. PubMed ID: 30293857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specialized pro-resolving mediator network: an update on production and actions.
    Chiang N; Serhan CN
    Essays Biochem; 2020 Sep; 64(3):443-462. PubMed ID: 32885825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators.
    Yasmeen N; Selvaraj H; Lakhawat SS; Datta M; Sharma PK; Jain A; Khanna R; Srinivasan J; Kumar V
    Biochem Pharmacol; 2023 Mar; 209():115437. PubMed ID: 36731803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developments of specialized pro-resolving mediators in periodontitis.
    Liu YC
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Feb; 39(1):94-98. PubMed ID: 33723943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid mediators in the resolution of inflammation.
    Serhan CN; Chiang N; Dalli J; Levy BD
    Cold Spring Harb Perspect Biol; 2014 Oct; 7(2):a016311. PubMed ID: 25359497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases.
    Miyata J; Arita M
    Allergol Int; 2015 Jan; 64(1):27-34. PubMed ID: 25572556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation.
    Duvall MG; Levy BD
    Eur J Pharmacol; 2016 Aug; 785():144-155. PubMed ID: 26546247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and Changes in Lipid Mediator Profiling after Consumption of Specialized Pro-Resolving Lipid-Mediator-Enriched Marine Oil in Healthy Subjects.
    Irún P; Carrera-Lasfuentes P; Sánchez-Luengo M; Belio Ú; Domper-Arnal MJ; Higuera GA; Hawkins M; de la Rosa X; Lanas A
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators.
    Serhan CN; Levy BD
    J Clin Invest; 2018 Jul; 128(7):2657-2669. PubMed ID: 29757195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?
    Serhan CN
    Am J Pathol; 2010 Oct; 177(4):1576-91. PubMed ID: 20813960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chiral lipidomics of E-series resolvins: aspirin and the biosynthesis of novel mediators.
    Oh SF; Vickery TW; Serhan CN
    Biochim Biophys Acta; 2011 Nov; 1811(11):737-47. PubMed ID: 21712098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The resolution of inflammation: Principles and challenges.
    Headland SE; Norling LV
    Semin Immunol; 2015 May; 27(3):149-60. PubMed ID: 25911383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathways involved in the resolution of inflammatory joint disease.
    Haworth O; Buckley CD
    Semin Immunol; 2015 May; 27(3):194-9. PubMed ID: 25944272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 66.